The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Genetic Mutation Analysis Market In 2026, And How Will Its Value Evolve By 2030?
The market for genetic mutation analysis has experienced significant expansion recently. Projections indicate its size will increase from $6.65 billion in 2025 to reach $7.43 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 11.7%. Historically, this expansion has been driven by factors such as limited access to advanced sequencing technologies, a growing awareness of genetic disorders, increasing research in oncology and inherited diseases, the adoption of PCR and microarray technologies, and the early development of bioinformatics tools.
The genetic mutation analysis market size is projected to experience swift expansion over the coming years. This market is anticipated to reach $11.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.5%. Several factors are expected to fuel this growth throughout the forecast period, including progress in crispr and ngs platforms, an increase in pharmacogenomics research, greater investments in genetic testing infrastructure, the incorporation of ai-driven data interpretation tools, and more partnerships between research institutions and biotechnology firms. Key trends anticipated during this period involve a greater embrace of next-generation sequencing and crispr technologies, growing need for personalized medicine and targeted therapies, the broadening of genetic testing services within clinical diagnostics, the merging of bioinformatics with data analysis platforms, and an uptick in studies concerning rare genetic disorders and pharmacogenomics.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27297&type=smp
What Key Factors Are Affecting The Genetic Mutation Analysis Market Demand?
The increasing occurrence of genetic disorders is anticipated to boost the expansion of the genetic mutation analysis market in the coming years. Genetic disorders are conditions resulting from DNA irregularities or alterations within an individual, which can either be passed down or emerge without prior inheritance. A contributing factor to the rising incidence of these disorders is the increased age of parents, which heightens the potential for genetic mutations during conception, consequently increasing the probability of such conditions in children. Genetic mutation analysis serves to identify alterations in genes that may cause or indicate the existence of genetic disorders, facilitating prompt diagnosis, specific therapies, and well-informed choices regarding reproduction or lifestyle. As an illustration, in October 2024, data from the Cystic Fibrosis Trust revealed that 11,148 cystic fibrosis patients were registered in 2022, a figure that climbed to 11,318 in 2023, showing a 1.5% rise in patient registrations annually. Thus, the growing prevalence of genetic disorders is a key factor propelling the growth of the genetic mutation analysis market.
What Are The Main Segments Within The Genetic Mutation Analysis Market Segment Structure?
The genetic mutation analysis market covered in this report is segmented –
1) By Component: Hardware, Software, Services
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Sanger Sequencing, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
3) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Genetic Disorders, Pharmacogenomics
4) By End User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories
Subsegments:
1) By Hardware: Sequencers, Polymerase Chain Reaction (PCR) Machines, Microarray Instruments, Electrophoresis Systems, Imaging Systems
2) By Software: Data Analysis Software, Sequence Alignment Tools, Variant Calling Software, Genome Annotation Software, Visualization Tools
3) By Services: Genetic Testing Services, Data Interpretation Services, Bioinformatics Services, Sample Preparation Services, Clinical Reporting Services
What Market Trends Are Affecting The Genetic Mutation Analysis Market?
Leading firms within the genetic mutation analysis market are concentrating on creating novel solutions, including tissue-based next-generation sequencing (NGS) tests, aimed at improving accuracy in detecting significant genetic changes and informing individualized treatment plans. These tissue-based next-generation sequencing (NGS) tests serve as sophisticated diagnostic instruments, examining DNA or RNA from tissue samples to uncover genetic mutations, alterations, or biomarkers linked to conditions like cancer. As an illustration, in June 2024, Guardant Health Inc., a US-based oncology company, introduced the Guardant360 TissueNext test, which now identifies 498 genes in a tumor tissue sample. These genes, also known as cancer biomarkers, assist oncologists in pinpointing the most effective targeted therapies or treatment approaches for individuals with advanced cancer. Beyond the expanded gene panel, Guardant has refined the test’s operational processes to achieve a quicker turnaround time. The new Guardant360 TissueNext test will receive coverage for Medicare fee-for-service patients suffering from advanced solid tumor cancers as a distinct service. This coverage is based on the determination provided by Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostics Services program (MolDX), under its current local coverage policy.
Who Are The Companies Participating In The Genetic Mutation Analysis Market?
Major companies operating in the genetic mutation analysis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies Plc, Genomic Health Inc., Color Genomics Inc., Blueprint Medicines Corporation, GENEWIZ Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Personalis Inc., LGC Biosearch Technologies LLC, BGI Genomics Co. Ltd.
Get The Full Genetic Mutation Analysis Market Report:
https://www.thebusinessresearchcompany.com/report/genetic-mutation-analysis-global-market-report
Where Is The Genetic Mutation Analysis Market Most Concentrated Geographically?
North America was the largest region in the genetic mutation analysis market in 2025. The regions covered in the genetic mutation analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Genetic Mutation Analysis Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/genetic-mutation-analysis-global-market-report
Browse Through More Reports Similar to the Global Genetic Mutation Analysis Market 2026, By The Business Research Company
Mining Equipment Market Report 2026
https://www.thebusinessresearchcompany.com/report/mining-equipment-global-market-report
Electric Mining Equipment Market Report 2026
https://www.thebusinessresearchcompany.com/report/electric-mining-equipment-global-market-report
Autonomous Mining Equipment Market Report 2026
https://www.thebusinessresearchcompany.com/report/autonomous-mining-equipment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model